AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
Filed 1w ago · Via finance.yahoo.com · The Buffoon Desk
THIS STORY IS SCORED
Bass Walker
Kevin MacLeod · incompetech.com · CC BY 4.0
AngioDynamics says it expects its MedTech segment to become the majority of company revenue by fiscal 2027, according to the headline. No further article detail was provided on current figures or the timeline to get there.
The full dispatch is available from the source below.